Abstract
Preface.- Pandemic influenza as a current threat.- Designing vaccines for pandemic influenza.- Current vaccines for seasonal influenza.- Generation and characterization of candidate vaccine viruses for pre-pandemic influenza vaccines.- Recombinant proteins produced in insect cells.- Adjuvants for pandemic influenza vaccines.- Live attenuated vaccines for pandemic influenza.- Influenza vaccines for avian species.- Development and application of avian influenza vaccines in China.- Attenuated influenza virus vaccines with modified NS1 proteins.- DNA Vaccines against Influenza viruses.- Influenza neuraminidase as a vaccine antigen.- Recombinant vectors as influenza vaccines.- Universal Pandemic Influenza Vaccines.- Influenza virus-like particles as pandemic vaccines.- Antigenic cross-reactivity among H5N1 viruses.- Transcutaneous immunization with influenza vaccines.- Self-administered microneedle patches for pandemic influenza.- Animal models for evaluation of influenza vaccines.- Immunosenescence and influenza vaccine efficacy.- Summary of recent clinical trials.- Considerations for licensure of pandemic and pre-pandemic indications in the U.S..- Strategies for Broad Global Access to Pandemic Influenza Vaccines.- Prioritization of Pandemic Influenza Vaccine: Rationale and Strategy for Decision-Making.- Subject index.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
